Clostridium difficile associated diseases;Clostridium-difficile-assoziierte erkrankungen

Gastroenterologe

Volumn 2, Issue 1, 2007, Pages 53-63

  Schlottmann, R ^a   Kaup, B ^a   Kaase, M ^b   Tannapfel, A ^c   Schmidt, W E ^a   Schmitz, F ^d  

^a ST JOSEF HOSPITAL   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d Klinikum Hildesheim   (Germany)

Author keywords

Antibiotic associated diarrhea; Clostridium difficile; Nosocomial diarrhea; Nosocomial infection; Pseudomembranous enterocolitis

Indexed keywords

EID: 33846342493     PISSN: 18619681     EISSN: 1861969X     Source Type: Journal    
DOI: 10.1007/s11377-006-0058-1     Document Type: Review

References (18)

1. Aslam S, Hamill R, Musher D (2005) Treatment of Clostridium difficile-associated disease: old therapies and new strategies. Lancet Infect Dis 5: 549-557
2. Barbut F, Petit J (2001) Epidemiology of Clostridium difficile-associated infections. Clin Microbiol Infect 7: 405-410
3. Bartlett J (2002) Antibiotic-associated diarrhea. N Engl J Med 346: 334-339
4. Bricker E, Garg R, Nelson R et al. (2005) Antibiotic treatment for Clostridium difficile-associated diarrhea in adults (Cochrane Review). Cochrane Database Syst Rev 1: CD004610
5. Fekety R (1997) Guidelines for the diagnosis and treatment of Clostridium difficile-associated diarrhea and colitis. Am J Gastroenterol 92: 739-750
6. Gerding D, Johnson S, Peterson L et al. (1995) Clostridium difficile-associated diarrhea and colitis. SHEA Position Paper. Infect Control Hosp Epidemiol 16: 459-477
7. Kelly C, Pothoulakis C, LaMont T (1994) Clostridium difficile Colitis. N Engl J Med 330: 257-262
8. Kuijper E, Coignard B, Tull P et al. (2006) Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect (Suppl 6) 12: 2-18
9. Loo V, Poirier L, Miller M et al. (2005) A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 353: 2442-9
10. Maroo S, Lamont J (2006) Recurrent Clostridium difficile. Gastroenterology 130: 1311-1316
11. Muto CA, Pokrywka M, Shutt K et al. (2005) A large outbreak of clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased flourchinolone use. Infect Control Hosp Epidemiol 26: 273-280
12. Mylonakis E, Ryan ET, Calderwood SB (2001) Clostridium difficile-associated diarrhea. Arch Intern Med 161: 525-533
13. Robert Koch Institut (2006) Empfehlungen des Robert Koch-Institutes zu Hygienemaßnahmen bei Patienten mit Durchfällen aufgrund von toxinbildendem Clostridium difficile. Stand: 11.8.2006. http://www.rki.de
14. Voth D, Ballard J (2005) Clostridium difficile toxins: mechanisms of action and role in disease. Clin Microbiol. Reviews 18: 247-263
15. Teasley DG, Gerding DN, Olson MM et al. (1983) Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis. Lancet 2: 1043-1046
16. Wenisch C, Parschalk B, Hasenhundl M et al. (1996) Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea. Clin Infect Dis 22: 813-818, Eratum in Clin Infect Dis 23: 423
17. Surawicz CM, Elmer GW, Speelman P et al. (1989) Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology 96: 981-988
18. Leung DY, Kelly CP, Boguniewicz M et al. (1991) Treatment with intravenously-administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin. J Pediatr 118: 633-637